Status:

COMPLETED

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

Lead Sponsor:

Hoffmann-La Roche

Conditions:

Lymphocytic Leukemia, Chronic

Eligibility:

All Genders

65+ years

Phase:

PHASE2

Brief Summary

This single arm, open-label study will assess the safety and efficacy of low dose fludarabine and cyclophosphamide in combination with standard dose MabThera/Rituxan (rituximab) as primary therapy in ...

Eligibility Criteria

Inclusion

  • Adult patients, \>/= 65 years of age
  • Previously untreated B-cell chronic lymphocytic leukemia (CLL)
  • Binet stage C or active Binet stage A and B disease

Exclusion

  • Prior treatment for CLL
  • CLL with transformation (Richter's syndrome)
  • Suspected or known central nervous system (CNS) involvement of CLL
  • Impaired renal or hepatic function
  • Human Immunodeficiency Virus (HIV) positivity, active hepatitis B/C or Hepatitis B Virus (HBV) surface antigen positive, or any active or uncontrolled infections
  • Patients with anti-HBV core antibodies (past infection with HBV) but who are negative for Hepatitis B Virus Surface Antigen (HBVsAg) (either anti-HBS Ab positive or negative) and are positive for HBV- Deoxyribonucleic acid (DNA) by Polymerase chain reaction (PCR) analysis
  • Concomitant diseases requiring chronic steroid administration
  • Active second malignancy within the 2 years prior to study (except for non-melanoma skin cancer and in situ cervix or breast or prostate carcinoma)
  • Eastern Cooperative Oncology Group (ECOG) performance status \>/= 3

Key Trial Info

Start Date :

July 17 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 3 2017

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT01263704

Start Date

July 17 2011

End Date

April 3 2017

Last Update

April 23 2018

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Haemek Medical Center; Hematology Department

Afula, Israel, 18101

2

Soroka Medical Center; Hematology Deptartment

Beersheba, Israel, 8410101

3

Rambam Medical Center; Heamatology & Bone Marrow Transplantation

Haifa, Israel, 3109601

4

Bnei-Zion Medical Center; Hematology Dept

Haifa, Israel, 3339419